Top & Current
Thu, May 16, 2024
[ Thu, May 16th 2024
] - WOPRAI
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
Tue, May 14, 2024
[ Tue, May 14th 2024
] - WOPRAI
Wed, April 10, 2024
[ Wed, Apr 10th 2024
] - WOPRAI
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
Wed, March 27, 2024
[ Wed, Mar 27th 2024
] - WOPRAI
[ Wed, Mar 27th 2024
] - WOPRAI
Tue, February 6, 2024
[ Tue, Feb 06th 2024
] - WOPRAI
Fri, January 19, 2024
[ Fri, Jan 19th 2024
] - WOPRAI
Thu, November 16, 2023
[ Thu, Nov 16th 2023
] - WOPRAI
Wed, November 15, 2023
[ Wed, Nov 15th 2023
] - WOPRAI
Tue, September 26, 2023
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
[ Tue, Sep 26th 2023
] - WOPRAI
Tue, August 22, 2023
[ Tue, Aug 22nd 2023
] - WOPRAI
Wed, May 17, 2023
[ Wed, May 17th 2023
] - WOPRAI
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
Fri, January 20, 2023
[ Fri, Jan 20th 2023
] - WOPRAI
Ross Osborn Reiterated (VNRX) at Buy and Held Target at $2.5 on, May 16th, 2024
Ross Osborn of Cantor Fitzgerald, Reiterated "VolitionRx Limited" (VNRX) at Buy and Held Target at $2.5 on, May 16th, 2024.
Ross has made no other calls on VNRX in the last 4 months.
There is 1 other peer that has a rating on VNRX. Out of the 1 peers that are also analyzing VNRX, 0 agree with Ross's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ross
- Tim Moore of "EF Hutton" Maintained at Strong Buy and Held Target at $4.5 on, Tuesday, May 14th, 2024